UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 846

Sortiert nach

Drug harms in the UK: a multicriteria decision analysis

The Lancet (British edition), 2010-11, Vol.376 (9752), p.1558-1565

2010

Link zum Volltext

Verfügbarkeit prüfen

Bayesian analysis of real‐world data as evidence for drug approval: Remembering Sir Michael Rawlins

British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2646-2648

2023

Link zum Volltext

Verfügbarkeit prüfen

So near yet so far: why won’t the UK prescribe medical cannabis?

BMJ open, 2020-09, Vol.10 (9), p.e038687-e038687

2020

Link zum Volltext

Verfügbarkeit prüfen

The value of real world evidence: The case of medical cannabis

Frontiers in psychiatry, 2022-11, Vol.13, p.1027159-1027159

2022

Link zum Volltext

Verfügbarkeit prüfen

Advancing structured decision‐making in drug regulation at the FDA and EMA

British journal of clinical pharmacology, 2021-02, Vol.87 (2), p.395-405

2021

Link zum Volltext

Verfügbarkeit prüfen

ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual Considerations

Value in health, 2020-08, Vol.23 (8), p.1040-1048

2020

Link zum Volltext

Verfügbarkeit prüfen

Quantifying Preferences in Drug Benefit‐Risk Decisions

Clinical pharmacology and therapeutics, 2019-11, Vol.106 (5), p.955-959

2019

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

European addiction research, 2014-01, Vol.20 (5), p.218-225

2014

Link zum Volltext

Verfügbarkeit prüfen

Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing

Annals of operations research, 2007-10, Vol.154 (1), p.51-68

2007

Link zum Volltext

Verfügbarkeit prüfen

E-cigarettes are less harmful than smoking

The Lancet (British edition), 2016-03, Vol.387 (10024), p.1160-1162

2016

Link zum Volltext

Verfügbarkeit prüfen

Medical cannabis in the UK: From principle to practice

Journal of Psychopharmacology, 2020-09, Vol.34 (9), p.931-937

2020

Link zum Volltext

Verfügbarkeit prüfen

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

Pharmacoepidemiology and drug safety, 2014-07, Vol.23 (7), p.667-678

2014

Link zum Volltext

Verfügbarkeit prüfen

Recommendations for benefit-risk assessment methodologies and visual representations

Pharmacoepidemiology and drug safety, 2016-03, Vol.25 (3), p.251-262

2016

Link zum Volltext

Verfügbarkeit prüfen

Nuclear Risk Management on Stage: A Decision Analysis Perspective on the UK's Committee on Radioactive Waste Management

Risk analysis, 2009-05, Vol.29 (5), p.764-779

2009

Link zum Volltext

Verfügbarkeit prüfen

Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex

European urology focus, 2020-05, Vol.6 (3), p.522-530

2020

Link zum Volltext

Verfügbarkeit prüfen

Literature review of visual representation of the results of benefit-risk assessments of medicinal products

Pharmacoepidemiology and drug safety, 2016-03, Vol.25 (3), p.238-250

2016

Link zum Volltext

Verfügbarkeit prüfen

Multi-Criteria Decision Analysis to Develop an Efficacy-Safety Profile of Parenteral Analgesics Used in the Treatment of Postoperative Pain

Journal of pain research, 2020-01, Vol.13, p.1969-1977

2020

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum re “Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex” [Eur Urol Focus 2020;6:522–30]

European urology focus, 2022-01, Vol.8 (1), p.360-361

2022

Link zum Volltext

Verfügbarkeit prüfen

Structured Approaches to Benefit-Risk Assessment: A Case Study and the Patient Perspective

Therapeutic innovation & regulatory science, 2014-09, Vol.48 (5), p.564-573

2014

Link zum Volltext

Verfügbarkeit prüfen

Selecting pH cut-offs for the safe verification of nasogastric feeding tube placement: a decision analytical modelling approach

BMJ open, 2017-11, Vol.7 (11), p.e018128-e018128

2017

Link zum Volltext

Verfügbarkeit prüfen

Comment on “Whose Judgement? Reflections on Elicitation in Bayesian Analysis”

Decision analysis

Link zum Volltext

Verfügbarkeit prüfen

Risk Perception of Prescription Drugs: Results of a Survey Among Experts in the European Regulatory Network

Medical decision making, 2013-05, Vol.33 (4), p.579-592

2013

Link zum Volltext

Verfügbarkeit prüfen

Modelling the risk-benefit impact of H1N1 influenza vaccines

European journal of public health, 2013-08, Vol.23 (4), p.674-678

2013

Link zum Volltext

Verfügbarkeit prüfen

Risks of Using Bedside Tests to Verify Nasogastric Tube Position in Adult Patients

EMJ. Gastroenterology, 2014-12, Vol.3 (1), p.49-56

2014

Link zum Volltext

Verfügbarkeit prüfen

Expert Judgment and Expert Systems

1, 1987

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 846

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(721)
Mit Volltextzugriff
(653)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(453)
EZB Electronic Journals Library
(355)
RCN full-text journals@Ovid
(348)
Ingenta
(314)
Single Journals
(238)
IngentaConnect Journals
(171)
Elsevier ScienceDirect Journals Complete
(138)
Wiley Online Library
(105)
Elsevier ScienceDirect Journals Complete
(79)
Wiley Online Library
(72)
Taylor & Francis
(68)
Taylor & Francis Online
(63)
JSTOR All Journals
(55)
SpringerLink (Online service)
(53)
Ebook Central Perpetual and DDA
(47)
Nature Journals
(47)
eBooks on EBSCOhost
(46)
Oxford University Press Journals Current
(40)
EBSCOhost Psychology and Behavioral Sciences Collection
(33)
Springer Books
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Drug harms in the UK: a multicriteria decision analysis

Bayesian analysis of real‐world data as evidence for drug approval: Remembering Sir Michael Rawlins

So near yet so far: why won’t the UK prescribe medical cannabis?

The value of real world evidence: The case of medical cannabis

Advancing structured decision‐making in drug regulation at the FDA and EMA

ICER Value Framework 2020 Update: Recommendations on the Aggregation of Benefits and Contextual Considerations

Quantifying Preferences in Drug Benefit‐Risk Decisions

Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach

Transparent prioritisation, budgeting and resource allocation with multi-criteria decision analysis and decision conferencing

E-cigarettes are less harmful than smoking

Medical cannabis in the UK: From principle to practice

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies

Recommendations for benefit-risk assessment methodologies and visual representations

Nuclear Risk Management on Stage: A Decision Analysis Perspective on the UK's Committee on Radioactive Waste Management

Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex

Literature review of visual representation of the results of benefit-risk assessments of medicinal products

Multi-Criteria Decision Analysis to Develop an Efficacy-Safety Profile of Parenteral Analgesics Used in the Treatment of Postoperative Pain

Corrigendum re “Multicriteria Decision Analysis Applied to the Clinical Use of Pharmacotherapy for Overactive Bladder Symptom Complex” [Eur Urol Focus 2020;6:522–30]

Structured Approaches to Benefit-Risk Assessment: A Case Study and the Patient Perspective

Selecting pH cut-offs for the safe verification of nasogastric feeding tube placement: a decision analytical modelling approach

Comment on “Whose Judgement? Reflections on Elicitation in Bayesian Analysis”

Risk Perception of Prescription Drugs: Results of a Survey Among Experts in the European Regulatory Network

Modelling the risk-benefit impact of H1N1 influenza vaccines

Risks of Using Bedside Tests to Verify Nasogastric Tube Position in Adult Patients

Expert Judgment and Expert Systems

Suchergebnisse filtern